WO2010052596A1 - Method and system for ultrasound therapy - Google Patents
Method and system for ultrasound therapy Download PDFInfo
- Publication number
- WO2010052596A1 WO2010052596A1 PCT/IB2009/054483 IB2009054483W WO2010052596A1 WO 2010052596 A1 WO2010052596 A1 WO 2010052596A1 IB 2009054483 W IB2009054483 W IB 2009054483W WO 2010052596 A1 WO2010052596 A1 WO 2010052596A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasound
- ablation
- shapes
- ultrasound ablation
- imaging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/374—NMR or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0078—Ultrasound therapy with multiple treatment transducers
Definitions
- Ultrasound techniques are becoming a desirable approach for therapeutic interventions due in part to their non-invasive nature.
- the use of ultrasound in these applications allows non-invasive treatment of deep tissues.
- the use of high-intensity focused ultrasound is being used by users for thermal therapeutic intervention of uterine fibroids.
- Ultrasound therapy for tissue ablation includes insonifying a tissue of interest with high intensity ultrasound that is absorbed and converted into heat, raising the temperature of the tissues. As the temperature rises above 55°C, coagulative necrosis of the tissues occurs resulting in immediate cell death.
- the ultrasound lesions used for tumor ablation are typically cigar-shaped, with a length along the ultrasound propagation direction and a width along the transverse direction.
- these ultrasound lesions can vary with the spatial location of the beam itself. For instance, when the ultrasound beam is made to focus on a tissue that is deep from the transducer, the beam sizes are typically much larger than the case when the beams are steered closer to the transducer. Also, when the ultrasound beams are steered off-axis, they tend to be larger and more elongated than the case where they are focused along the propagation axis. Typical dimensions of the ultrasound beam are 1 to 2 cm along propagation axis, and 1-2 mm in the transverse directions. The ultrasound lesion sizes depend not only on the ultrasound beam characteristics, but also on the sonication time.
- the ultrasound beam In order to optimally treat tumors that are larger than the size of a single ultrasound lesion, the ultrasound beam needs to be repositioned in different parts of the tumor. This process is repeated until the entire tumor is covered with multiple ultrasound lesions or ablations.
- doctors treat an additional small margin encompassing the tumor to also treat microscopic cancerous tissue that may not be visible in the diagnostic imaging scans of the tumor.
- the tumor and margin is also knows as the Planned Target Volume (PTV).
- PTV Planned Target Volume
- the placement of these ultrasound lesions one next to the other to achieve a three dimensional treatment volume is done in a non-optimal manner.
- a sequence of multiple overlapping ablations has to be created. Even if the PTV is only slightly larger than an individual ablation, a large number of ablations may be required, making the task of planning the composite ablation difficult to perform, especially in three dimensions.
- An example of a planning tool for computing a composite ablation to cover an arbitrary PTV with multiple overlapping ablations is described in patent publication WO/2008/090484, the disclosure of which is hereby incorporated by reference. Although the publication describes a coverage algorithm for radiofrequency ablation planning, it can be used to compute the number and placement of ultrasound ablations. The planning tool uses a typical ablation shape to cover the PTV.
- Contemporary devices using ultrasound ablation such as the Sonablate® or Ablatherm® devices for prostate treatment, employ a mechanically focused transducer that has the same beam shape everywhere the focus is moved and employs straightforward placement of ablation lesions next to one another.
- dead spots between the ultrasound lesions or an unnecessarily large number of lesions with significant overlap in between are of concern.
- the actual observed ablation lesions can vary depending on many factors such as the local perfusion levels (e.g., presence of a major blood vessel nearby), the local ultrasound absorption rates, and the unknown intervening tissue attenuation. Since these are unknown a priori, the previously pre-planned treatment protocol is often inadequate and the actual lesions are smaller or larger than the planned ablation shapes. The procedure could use an unnecessarily large number of overlapping lesions if the actual lesions are larger than expected. On the other hand if the lesions were smaller than expected, the treatment could leave unablated gaps in the treatment volume.
- Contemporary implementations of ultrasound ablation therapy try to cover a tumor volume by systematically exposing adjacent regions of tissue to thermal energy.
- One method can be by applying energy for longer durations of time at one location and diffusing the heat outwards from that point such that it covers the entire volume.
- Another method can be by scanning the region in a systematic manner by sequentially ablating small regions of tissue and moving the focus spot in a geometric scanning pattern to cover the entire volume.
- Neither of these contemporary techniques provides optimum locations for those ablations in terms of either improving the coverage of a planned target volume that contains the diseased region of tissue, minimizing damage to healthy tissue, or minimizing the total procedure time. All of these factors can be important based on the patient's prognosis and available procedure time.
- a method can include obtaining first imaging of a region of interest; delineating a planned target volume using the first imaging; selecting ultrasound ablation shapes from a library of ultrasound ablation shapes; performing first ultrasound ablation on the planned target volume using the selected ultrasound ablation shapes; obtaining second imaging of the region of interest after performing the first ultrasound ablation; and adjusting the selected ultrasound ablation shapes based at least in part on the second imaging.
- a computer-readable storage medium can include computer-executable code stored therein, where the computer- executable code is configured to cause a computing device in which the computer-readable storage medium is loaded to execute the steps of obtaining first imaging of a region of interest; receiving a selection of a planned target volume using the first imaging; selecting ultrasound ablation shapes from a library of ultrasound ablation shapes; performing first ultrasound ablation on the planned target volume using an ultrasound transducer that applies energy based on the selected ultrasound ablation shapes; obtaining second imaging of the region of interest after performing the first ultrasound ablation; selecting other ultrasound ablation shapes from the library of ultrasound ablation shapes based at least in part on the second imaging; and performing second ultrasound ablation based at least in part on the selected other ultrasound ablation shapes.
- an ultrasound ablation system can include an imaging device for capturing first imaging of a region of interest, a processor for receiving a selection of a planned target volume using the first imaging, and an ultrasound transducer for performing first ultrasound ablation on the planned target volume.
- the processor can select ultrasound ablation shapes from a library of ultrasound ablation shapes.
- the ultrasound transducer can apply energy to the planned target volume based at least in part on the selected ultrasound ablation shapes.
- the imaging device can capture second imaging of the region of interest after application of the first ultrasound ablation.
- the processor can select other ultrasound ablation shapes from the library of ultrasound ablation shapes based at least in part on the second imaging.
- the processor can include a planning tool to plan the coverage of a tumor with overlapping ablations.
- the planning tool can use the library of available ablation shapes to cover the PTV. It can optimize one or more clinical objectives, such as guaranteeing the coverage of the entire PTV, minimizing the number of ablations, minimizing the ablation of healthy tissue, avoiding critical tissue, minimizing total treatment time, and so forth.
- the result of the planning tool can be a treatment plan.
- the plan can be accepted for continuation of the treatment after evaluation by the doctor.
- the planning tool can rapidly recalculate treatment plans as necessary enabling the doctor to re-weight objectives and/or modify physical parameters of the executed treatment.
- the planning tool can also visualize the treatment plan in the form of a graphical interface depicting the focal points for energy delivery and the ultrasound lesion shapes at those points as determined from the library.
- the exemplary embodiments used for the ultrasound-based tissue ablation can involve a combination of utilizing imaging information, the physical parameters of ablation therapy and positional feedback at the time of treatment.
- the exemplary embodiments described herein can have a number of advantages over contemporary systems and processes, including reducing or eliminating dead spots between the ultrasound lesions and/or eliminating any unnecessarily large number of lesions with significant overlap.
- the exemplary embodiments described herein can provide for an efficient ultrasound ablation treatment of tissue, through reduced time and reduced ultrasound exposure.
- Figure 1 is a schematic illustration of an exemplary embodiment of a system for use in ultrasonic ablation
- Figure 2 depicts a spatial map illustrating the layout of ablations created with a phased ultrasonic array
- Figure 3 depicts imaging with an applied treatment plan according to an embodiment of the present invention
- Figure 4 depicts imaging with another applied treatment plan according to an embodiment of the present invention.
- Figure 5 is a method that can be used by the system of FIG. 1 for ultrasound ablation.
- the exemplary embodiments described herein provide a system and method of providing ultrasound ablation therapy in a PTV.
- the system and method has a number of advantages including ensuring more effective treatment through calculation of more accurate treatment volumes; ensuring adequate coverage and ensuring critical treatment regions (e.g., tumors) are not missed; reducing damage to healthy tissues since an optimal number of lesion locations can be used rather than a larger number which can cause unnecessary damage to healthy tissues as the skin; minimizing treatment duration (e.g., if perfusion is low then the treatment can be made faster for that local region by reducing the sonication time).
- the exemplary embodiments of the present disclosure can include either or both of a feedback tool for updating intra-procedurally the placement of subsequent ablation volumes in the tissue and updating treatment protocol for subsequent locations.
- the exemplary embodiments can provide a planning tool that allows a new treatment plan to be evaluated by the user, including users, physicians, operators, technicians or other individuals, prior to continuing the procedure and ensuring rapid calculation of treatment plans allows for re-weighting of objectives to calculate any modifications.
- the planning and feedback tool can include methods to visualize the treatment plan in terms of focal points for energy delivery and expected tissue damage surrounding the focal points individually or aggregated over all ablations.
- the system and method of the present disclosure can include an imaging device to acquire anatomical information from a patient (e.g., CT, ultrasound or MRI images); a system for user-based graphical delineation of one or more PTVs; and/or a library of tissue, transducer, and/or excitation dependent ablation shapes.
- a patient e.g., CT, ultrasound or MRI images
- a system for user-based graphical delineation of one or more PTVs e.g., CT, ultrasound or MRI images
- a library of tissue, transducer, and/or excitation dependent ablation shapes e.g., the ablation shapes can be pre-computed by a thermal acoustic modeling tool and/or obtained through experiments.
- the library may be stored in a memory or storage device, or can be computed during the calculation of the treatment plan.
- the system and method of the present disclosure can include a system for user-based interaction that allows the user to select a set of ablation shapes from the library of ablation shapes; a planning tool that calculates a set of ablations that satisfies a set of previously-stated objectives; a system for user-based weighting of the objectives used by the planning tool; a visualization device for visualizing the treatment plan in terms of focal points for energy delivery and expected tissue damage surrounding the focal points individually or aggregated over all ablations; an intra-procedural system to monitor ablation volumes (e.g., through imaging means such as MRI or ultrasound elastography); a feedback module that communicates the observed ablation shapes to the planning module; and/or a re-calculation module for recalculating and updating the set of ablation locations and shapes for ablating the remaining (e.g., untreated) portion of the treatment volume.
- a system for user-based interaction that allows the user to select a set of ablation shapes from the library of ablation shapes
- an ultrasound ablation system 10 can have an imaging device or system 50 and an ultrasound device or system 150 that can be utilized for ablation therapy in a patient 20.
- the particular type of ablation therapy can vary, including treatment of uterine fibroids, as well as liver, brain, prostate, and other cancerous lesions.
- Each of the systems 50 and 150 can be in communication with a processor 75 having a display device 80 (e.g., a monitor) connected thereto.
- a display device 80 e.g., a monitor
- the imaging system 50 can be an independent system that is utilized for obtaining images of the patient 20 prior to commencing the procedure while another imaging system can be utilized for providing imaging feedback as will be described again later.
- imaging system 50 can utilize MRI imaging, such as the system depicted in FIG. 1 using an open MRI device.
- System 50 can provide the user with images of the target region that can be delineated or otherwise marked to establish the PTV.
- the particular modality of the images can vary, such as ultrasound and CT modalities, and can also include combinations of modalities so that the user has a better depiction of the treatment area.
- the system 50 can acquire the images, display them on monitor 80 using the processor 75, and then provide a user interface for delineating the PTV.
- the processor 75 can import the images of the patient and provide for delineation with graphical tools that can create and adjust (e.g., move, rotate, scale and so forth) the three- dimensional outline of the diseased tissue.
- each region can be identified and classified as a PTV.
- the user can outline critical structures that are near the PTV which are not intended to be damaged by the ultrasonic therapy system.
- the PTV and critical regions can be recorded for use by a planning tool 76 of the processor 75.
- the ultrasound system 150 can include an ultrasound controller 160 and an ultrasound transducer or probe 170.
- the particular type of ultrasound controller 160, transducer 170 and other ultrasound components that are utilized by system 10 can vary, and the particular ultrasound techniques can also vary.
- the transducer being an internal transducer that delivers ultrasound energy to tissue positioned internally or in hard to reach places.
- the transducer 170 can have a size and shape that allows it to be inserted into the patient's body to the PTV, such as through a cannula, and can include being positioned through vessels, urethra, rectum, and so forth in the patient.
- the controller 160 can include components and/or utilize techniques associated with steering and electronic focusing of the ultrasound waves of the transducer 170.
- controller 160 or one or more of its components can be incorporated into, or shared with, processor 75, such as for data processing and presentation techniques.
- Transducer 170 can include an array of transducer or acoustic elements for the transmission of ultrasonic waves and for the receipt of ultrasonic echo signals.
- transducer 170 can provide for steering and electronic focusing of the ultrasound waves with respect to the target region to be treated. By appropriately delaying the pulses applied to each transducer element, the transducer 170 can transmit a focused ultrasound beam along a desired transmit scan line.
- the array transducer 170 can include a two-dimensional array such as disclosed in U.S. Pat. No. 6,428,477, assigned to the assignee of the present disclosure and incorporated herein by reference.
- system 10 can deliver ultrasound therapy beams that are highly focused, e.g., high- intensity focused ultrasound (HIFU).
- HIFU high- intensity focused ultrasound
- the planning tool 76 of the processor 75 can create a set of ablation shapes that are related to the tissue characteristics, the transducer's physical characteristics, and/or parameters chosen for the specific application of energy delivery through the transducer 170.
- the tissue characteristics can modulate the actual size and shape of the ablation lesions.
- the transducer's physical characteristics can include the number, shapes and location of the various basic elements that are actively used in the transducer 170, which influence the focal-point of an ablation lesion, and its corresponding shape.
- the energy delivery parameters can include the power applied and the exposure time at any given location.
- the combination of these transducer and tissue characteristics, and energy delivery parameters when used within an appropriately designed thermal acoustic modeling tool can provide a method to derive a library of ablation shapes that can be used by the planning tool 76.
- the planning tool 76 can choose between ablations of different shapes and sizes that best match one or more treatment objectives defined by the user. If the user has a weighting of the objectives into the processor 75, the planning tool 76 can adapt its results according to the weighting. A resulting treatment plan can be visualized graphically as shown for example in FIG. 3.
- the library of tissue, transducer, and excitation dependent ablation shapes can be created by a thermal acoustic modeling tool that utilizes knowledge of organ or tissue -type, the expected transducer characteristics and the parameters used for delivering the acoustical energy.
- the calculation of an ablation shape can be performed at a specific location in 3-D space with respect to the transducer's position. For instance, Table 1 shows an example of acoustic beam widths along the axial, transverse, and elevation directions for different ultrasonic array configurations: Table 1 :
- the acoustic beam width can be used to influence the ablation shape that results from using the acoustic beam with certain energy delivery parameters, e.g., power and time duration.
- Figure 2 shows actual ablation shapes for a given transducer when used at a specified focus location (e.g., indexed by axial and lateral distances from the transducer tip) for a specified amount of time as shown in Table 2:
- the planning tool 76 of processor 75 can combine an algorithm that covers the entire PTV with set of ablation shapes in which the shapes are restricted to be as defined in the library.
- the planning tool 76 can operate in conjunction with the set of user's objectives, such as minimizing the number of ablations over and above any consideration of total treatment time, or ablating more healthy tissue at the cost of total treatment time.
- the user can select from a list of weighting of objectives through a text or graphical based interface to the planning tool 76.
- Display device 80 can provide for a visualization of the treatment plan by depicting the ablation shapes overlaid on the PTV regions.
- the graphical depiction can include the focal points for energy delivery and expected shapes of the ablation surrounding the focal points either individually or aggregated over all ablations.
- This graphical depiction 300 is shown in FIG. 3, and includes the tissue in the region of interest 325, the PTV 350, the composite ablation 375, individual energy delivery focal points 380 and corresponding ablation shapes, and additional imaging slices in other imaging planes 385, 395.
- the composite ablation 375 can be composed with multiple ablation shapes , in this figure it includes only one shape of size 2cm x 0.25cm x 0.25cm.
- the graphical depiction 300 shows the total number of ablations as 115 and collateral damage as 11.4 cc of healthy tissue.
- the user can limit the planning tool 76 to use a limited set of ablation shapes from the library. This limit can reduce the processing time of the planning tool.
- the planning tool 76 can notify the user of how the transducer is most efficiently used.
- the planning tool 76 can account for constraints including the sequence of ablations given that distal ablations if performed early on in the procedure may not impact proximal ablations. This can reduce the complexity of the planning algorithm in that it reduces the search space of possible candidate ablation locations.
- the processor 75 can perform ablations with dead time for cooling to prevent damage to critical structures. The total time for the procedure can take this dead time into account.
- the planning tool 76 can adapt the sequence of ablations in a manner to cover separate PTVs to overlap the dead time for one region of interest with the active time for another. Even in the case of one region of interest, the exemplary embodiments can sequentially switch between sub-apertures of an ultrasonic array to ablate substantially different regions of the tissue in order to prevent damage to surface structures.
- Method 500 can commence with step 502 where images of a region of interest of a patient are obtained by processor 75.
- the region of interest can include one or more tumors or other treatment areas for the patient.
- a user can describe or otherwise establish one or more planned target volumes (PTVs) based on the pre -procedural image data sets.
- PTVs planned target volumes
- the processor 75 can obtain characteristics associated with the ultrasound transducer, such as power, transducer acoustic frequency, and f- number of the transducer.
- the processor 75 can select the ablation shaped from the library. For instance, a thermal acoustic modeling module can provide candidate ablation shapes based on the power, the transducer acoustic frequency, the f-number of transducer, and the duration of treatment for different spatial locations within the PTV, which are selected from the library of ablation shapes.
- the ablation shapes can be location specific.
- the planning tool 76 of the processor 75 can use the library of candidate ablations to pre-select a set of ablation shapes that completely cover the PTV without destroying critical structures that are healthy.
- the ablation therapy can be initiated by applying the ultrasound energy to the tissue.
- the processor 75 can perform intra-operative ablation shape monitoring through imaging feedback, e.g., MRI temperature mapping. While the exemplary embodiment describes MRI temperature measurements being utilized as the feedback mechanism, other imaging modalities can also be used, such as elastography techniques using ultrasound.
- the feedback can be obtained frequently, such as every 3 to 5 seconds where MRI imaging is being used for the feedback.
- the frequency of the feedback can be based on a number of factors including the type of imaging being used for feedback.
- the imaging feedback can provide a spatial map of what has been ablated so far during the procedure.
- Method 500 can determine if the ablation therapy has been completed in step 514 and if not then it can proceed to step 516 where the processor 75 can compare the actual ablated shapes and volumes with the pre -treatment estimates.
- the processor 75 can apply the feedback data for adjustment of the ablation therapy. For example, if the observed volumes are larger than the pre-determined estimates (e.g., there is less perfusion which tends to increase the temperature rise in that location), then the remaining ablation shapes for the remainder of the tissue (at least locally close to that lesion) can be chosen to be larger with fewer ablation points. This can be accomplished automatically and/or can be verified by the user before it takes effect. On the other hand if the observed ablation volumes are smaller than the pre-determined estimates, then the remaining ablation shapes can be chosen to be smaller in order to reduce or eliminate dead-spots in between.
- the pre-determined estimates e.g., there is less perfusion which tends to increase the temperature rise in that location
- the planning tool 76 using the feedback data can establish the degree of conformance of the observed ablation shape with the expected shape from the pre- procedural plan.
- the planning tool 76 can perform a re-calculation if the remaining pre- procedurally planned ablation locations and shapes would create a complete plan satisfying all the weighted objectives for the remaining tumor volume; and if not, it can re-calculate a new plan for the remaining tumor volume.
- the candidate library of ablation shapes can be updated based on the feedback data.
- the library, or a portion thereof, that has ablation shapes updated based on the feedback data can be made patient specific. For example as shown in FIG. 4, the treatment of a pre-determined volume of interest with lesion sizes of 2 cm x 0.35 cm x 0.35 cm is shown, which was selected based on nominal tissue parameters.
- This graphical depiction 400 shown in FIG. 4 includes the tissue 425, the PTV 450, the composite ablation 475, individual focal points for energy delivery 480 and corresponding ablation shapes, and additional imaging slices in other imaging planes 485, 495.
- Graphical depiction 400 shows treatment when a patient's perfusion is lower than expected leading to larger lesions so that only 69 lesions are needed to cover the PTV.
- processor 75 can utilize the captured feedback data capture to determine that the actual observed lesion size is larger than the pre-planned one, it would update the ablation size/shape in the library to reflect this information, the planning tool 76 would use the updated ablation shape from the library, and then re-calculate the plan with only 69 ablation lesions to cover the treatment volume.
- the original treatment plan had been continued without the benefit of intra-procedural feedback, it would have resulted in a 67% longer treatment time and also would have lead to a larger ultrasound dose to intervening tissues such as the skin surface.
- the perfusion and other properties could locally vary and certain sub-regions could use the smaller lesions and other sub-regions could use the larger lesion volumes. This treatment procedure can provide for full treatment with reduced treatment time.
- the system 10 can have a calibration step where ablation lesions are placed at a sufficient number of points in the PTV so as to sufficiently sample the lesion formation behavior throughout the PTV.
- these ablations can be performed in sequence.
- the observed lesions can then be compared to the pre-planned lesions to update the library of ablation size/shapes, and the planning tool 76 can re -plan the treatment protocol taking into account the updated ablation shapes at the different sampling locations.
- the treatment could then be initiated and would require less feedback during the actual procedure after the calibration step is completed.
- the exemplary embodiments provide for a pre -procedural calculation and graphical visualization of all ablation locations for execution of an ultrasonic therapy treatment.
- the plan allows for ablations to be created in a range of sizes and shapes based upon parameters of energy delivery.
- the planning tool 76 can utilize knowledge of the complete range of sizes and shapes that are described in the library of ablations.
- This library can be created in a number of ways, including an acoustic modeling tool that uses knowledge of organ or tissue type, as well as the expected transducer characteristics, and/or it can be created through experimental means.
- the exemplary embodiments also provide for the ability to create an treatment plan that can satisfy one or more of the following objectives: complete ablation of the PTV; minimizing the number of ablations; minimizing the thermal dose to the healthy tissue surrounding the PTV; maintaining safety (e.g., no ablation) for any identified critical structures; minimizing total procedure time; using a fixed set of ablation shapes from the library; and/or selecting a sequence of ablations that minimize thermal injury in the near-field.
- Treatment objectives can be weighted by the doctor prior to the procedure.
- the present disclosure provides for ensuring rapid calculation of treatment plans, which allows for re- weighting of objectives to calculate any modifications.
- the exemplary embodiments of the present disclosure are described with respect to ultrasound ablation therapy to treat tumors in a human. It should be understood by one of ordinary skill in the art that the exemplary embodiments of the present disclosure can be applied to other types of medical intervention and other portions of the body, whether human or animal, including for such other treatments as mediating clot dissolution (sonothrombolysis), mediating drug delivery and gene therapy, cosmetic means (e.g., removal of fat).
- the methods and systems described with respect to the exemplary embodiments can be used to increase the efficacy of existing medical treatments such as the use of tPA for stroke patients.
- the exemplary embodiments can be used with ultrasound mediated drug delivery and gene therapy.
- the exemplary embodiments described herein provide for the use of ultrasound for non-invasive treatment of deep tissues with little or no effect on overlying organs.
- the exemplary embodiments can also be applied to non-humans, such as in pre-clinical animal research.
- microbubble and/or nanoparticle ultrasound contrast agents can be used for imaging, targeting and delivery of therapeutic payloads as described with respect to the exemplary embodiments.
- the present disclosure also contemplates use of other energy delivery methods, including radio frequency ablation.
- the invention can be realized in hardware, software, or a combination of hardware and software.
- the invention can be realized in a centralized fashion in one computer system, or in a distributed fashion where different elements are spread across several interconnected computer systems. Any kind of computer system or other apparatus adapted for carrying out the methods described herein is suited.
- a typical combination of hardware and software can be a general purpose computer system with a computer program that, when being loaded and executed, controls the computer system such that it carries out the methods described herein.
- the invention can be embedded in a computer program product.
- the computer program product can comprise a computer-readable storage medium in which is embedded a computer program comprising computer-executable code for directing a computing device or computer-based system to perform the various procedures, processes and methods described herein.
- Computer program in the present context means any expression, in any language, code or notation, of a set of instructions intended to cause a system having an information processing capability to perform a particular function either directly or after either or both of the following: a) conversion to another language, code or notation; b) reproduction in a different material form.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Bioethics (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200980143525.8A CN102202735B (en) | 2008-11-04 | 2009-10-12 | Method and system for ultrasound therapy |
US13/126,188 US20110208055A1 (en) | 2008-11-04 | 2009-10-12 | Method and system for ultrasound therapy |
EP09741431.2A EP2352558B1 (en) | 2008-11-04 | 2009-10-12 | System for ultrasound therapy |
BRPI0914520A BRPI0914520A2 (en) | 2008-11-04 | 2009-10-12 | computer readable storage medium and ultrasound ablation system |
JP2011533859A JP5948057B2 (en) | 2008-11-04 | 2009-10-12 | Method and system for ultrasound therapy |
RU2011122671/14A RU2519378C2 (en) | 2008-11-04 | 2009-10-12 | Ultrasonic therapy method and system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11100208P | 2008-11-04 | 2008-11-04 | |
US61/111,002 | 2008-11-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010052596A1 true WO2010052596A1 (en) | 2010-05-14 |
Family
ID=41507791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2009/054483 WO2010052596A1 (en) | 2008-11-04 | 2009-10-12 | Method and system for ultrasound therapy |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110208055A1 (en) |
EP (1) | EP2352558B1 (en) |
JP (1) | JP5948057B2 (en) |
CN (1) | CN102202735B (en) |
BR (1) | BRPI0914520A2 (en) |
RU (1) | RU2519378C2 (en) |
WO (1) | WO2010052596A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102762160A (en) * | 2010-06-17 | 2012-10-31 | 奥林巴斯医疗株式会社 | Ultrasound suction system and ultrasound suction method |
EP2684581A1 (en) * | 2012-07-10 | 2014-01-15 | Samsung Electronics Co., Ltd | Method and apparatus for generating irradiation plan to be provided to focused ultrasound irradiation apparatus |
WO2016151111A1 (en) * | 2015-03-26 | 2016-09-29 | Koninklijke Philips N.V. | System and method for tumor ablation treatment planning including core tumor, margin and healthy tissue coverage |
EP3628251A1 (en) * | 2018-09-28 | 2020-04-01 | Koninklijke Philips N.V. | Ablation therapy planning system |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100198065A1 (en) * | 2009-01-30 | 2010-08-05 | VyntronUS, Inc. | System and method for ultrasonically sensing and ablating tissue |
WO2008017051A2 (en) | 2006-08-02 | 2008-02-07 | Inneroptic Technology Inc. | System and method of providing real-time dynamic imagery of a medical procedure site using multiple modalities |
US11264139B2 (en) * | 2007-11-21 | 2022-03-01 | Edda Technology, Inc. | Method and system for adjusting interactive 3D treatment zone for percutaneous treatment |
US11464578B2 (en) | 2009-02-17 | 2022-10-11 | Inneroptic Technology, Inc. | Systems, methods, apparatuses, and computer-readable media for image management in image-guided medical procedures |
US8690776B2 (en) | 2009-02-17 | 2014-04-08 | Inneroptic Technology, Inc. | Systems, methods, apparatuses, and computer-readable media for image guided surgery |
US20130072784A1 (en) * | 2010-11-10 | 2013-03-21 | Gnanasekar Velusamy | Systems and methods for planning image-guided interventional procedures |
EP2665520B1 (en) * | 2011-01-18 | 2018-11-21 | Koninklijke Philips N.V. | Therapeutic apparatus, computer program product, and method for determining an achievable target region for high intensity focused ultrasound |
JP6129833B2 (en) * | 2011-07-28 | 2017-05-17 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Ablation planning system |
JP6295395B2 (en) * | 2011-08-30 | 2018-03-20 | プロファウンド メディカル インク | Real-time control of high-intensity focused ultrasound using magnetic resonance imaging |
EP2636368A1 (en) * | 2012-03-05 | 2013-09-11 | Koninklijke Philips Electronics N.V. | Modification of a treatment plan using magnetic resonance data acquired during a cooling period |
US9439627B2 (en) * | 2012-05-22 | 2016-09-13 | Covidien Lp | Planning system and navigation system for an ablation procedure |
BR112015004443A2 (en) * | 2012-09-01 | 2017-07-04 | Koninklijke Philips Nv | method for the use of ultrasonic information for the treatment of ablation disorders, and system for the use of ultrasonic information for the treatment of ablation disorders |
RU2651875C2 (en) | 2012-09-01 | 2018-04-24 | Конинклейке Филипс Н.В. | Ultrasonic measurement of the volume flow for ablation planning |
RU2650598C2 (en) * | 2012-10-12 | 2018-04-16 | Профаунд Медикал Инк. | Multi-foci sonications for hyperthermia treatments using magnetic resonance-guided focussed ultrasound |
KR20140113172A (en) * | 2013-03-15 | 2014-09-24 | 삼성전자주식회사 | Method and apparatus for making a plan of ultrasonic irradiation, and an ultrasonic irradiation method |
EP2786781A1 (en) * | 2013-04-05 | 2014-10-08 | Koninklijke Philips N.V. | Real-time energy depositing therapy system controlled by magnetic resonance rheology |
WO2015025039A1 (en) * | 2013-08-23 | 2015-02-26 | Koninklijke Philips N.V. | Medical instrument with multiple displays for controlling a treatment system |
WO2015167980A1 (en) * | 2014-04-28 | 2015-11-05 | Brigham And Women's Hospital, Inc. | Real-time margin adaptation |
WO2016001849A1 (en) * | 2014-07-02 | 2016-01-07 | Koninklijke Philips N.V. | Lesion signature to characterize pathology for specific subject |
US9901406B2 (en) * | 2014-10-02 | 2018-02-27 | Inneroptic Technology, Inc. | Affected region display associated with a medical device |
CN105534593B (en) * | 2014-10-29 | 2019-04-23 | 深圳迈瑞生物医疗电子股份有限公司 | interventional ablation simulation system and method |
US10188467B2 (en) | 2014-12-12 | 2019-01-29 | Inneroptic Technology, Inc. | Surgical guidance intersection display |
US9949700B2 (en) | 2015-07-22 | 2018-04-24 | Inneroptic Technology, Inc. | Medical device approaches |
US9675319B1 (en) | 2016-02-17 | 2017-06-13 | Inneroptic Technology, Inc. | Loupe display |
US10278778B2 (en) | 2016-10-27 | 2019-05-07 | Inneroptic Technology, Inc. | Medical device navigation using a virtual 3D space |
US11259879B2 (en) | 2017-08-01 | 2022-03-01 | Inneroptic Technology, Inc. | Selective transparency to assist medical device navigation |
WO2019100212A1 (en) * | 2017-11-21 | 2019-05-31 | 深圳迈瑞生物医疗电子股份有限公司 | Ultrasonic system and method for planning ablation |
US11484365B2 (en) | 2018-01-23 | 2022-11-01 | Inneroptic Technology, Inc. | Medical image guidance |
JP7092346B2 (en) * | 2018-08-08 | 2022-06-28 | ソニア・セラピューティクス株式会社 | Image control device |
CN110465008B (en) * | 2019-08-28 | 2021-02-12 | 黄晶 | Focused ultrasound treatment system |
KR102486572B1 (en) * | 2021-01-05 | 2023-01-11 | (주)아이엠지티 | Focused ultrasound apparatus and method for treatment sequence of focused ultrasound using the same |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003076003A2 (en) * | 2002-03-06 | 2003-09-18 | Tomotherapy Incorporated | Method for modification of radiotherapy treatment delivery |
US20060293583A1 (en) * | 2005-06-27 | 2006-12-28 | Saracen Michael J | Method for automatic anatomy-specific treatment planning protocols based on historical integration of previously accepted plans |
US20070010805A1 (en) * | 2005-07-08 | 2007-01-11 | Fedewa Russell J | Method and apparatus for the treatment of tissue |
WO2007014026A2 (en) * | 2005-07-22 | 2007-02-01 | Tomotherapy Incorporated | System and method of detecting a breathing phase of a patient receiving radiation therapy |
US20070076846A1 (en) * | 2005-07-22 | 2007-04-05 | Ruchala Kenneth J | System and method of delivering radiation therapy to a moving region of interest |
WO2007123913A1 (en) * | 2006-04-17 | 2007-11-01 | Siemens Medical Solutions Usa, Inc. | Personalized prognosis modeling in medical treatment planning |
US20080033420A1 (en) * | 2006-08-04 | 2008-02-07 | Nields Morgan W | Methods for planning and performing thermal ablation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2050862C1 (en) * | 1992-04-07 | 1995-12-27 | Санкт-Петербургский государственный медицинский университет им.акад.И.П.Павлова | Device for treating tachyarrhythmia |
DE69431741T2 (en) * | 1993-03-12 | 2003-09-11 | Kabushiki Kaisha Toshiba, Kawasaki | Device for medical treatment with ultrasound |
JPH08252261A (en) * | 1995-03-17 | 1996-10-01 | Toshiba Corp | Ultrasonic medical treatment device |
US6245059B1 (en) * | 1999-04-07 | 2001-06-12 | Visx, Incorporated | Offset ablation profiles for treatment of irregular astigmation |
US7363071B2 (en) * | 1999-05-26 | 2008-04-22 | Endocare, Inc. | Computer guided ablation of tissue using integrated ablative/temperature sensing devices |
US6905492B2 (en) * | 2000-07-31 | 2005-06-14 | Galil Medical Ltd. | Planning and facilitation systems and methods for cryosurgery |
US6618620B1 (en) * | 2000-11-28 | 2003-09-09 | Txsonics Ltd. | Apparatus for controlling thermal dosing in an thermal treatment system |
US20040077952A1 (en) * | 2002-10-21 | 2004-04-22 | Rafter Patrick G. | System and method for improved diagnostic image displays |
EP1684655A2 (en) * | 2003-11-18 | 2006-08-02 | SciMed Life Systems, Inc. | System and method for tissue ablation |
US20080015664A1 (en) * | 2004-10-06 | 2008-01-17 | Podhajsky Ronald J | Systems and methods for thermally profiling radiofrequency electrodes |
JP2006136441A (en) * | 2004-11-11 | 2006-06-01 | Toshiba Corp | Apparatus and method for ultrasonic irradiation |
US20070016039A1 (en) * | 2005-06-21 | 2007-01-18 | Insightec-Image Guided Treatment Ltd. | Controlled, non-linear focused ultrasound treatment |
US20070055225A1 (en) * | 2005-09-07 | 2007-03-08 | Dodd Gerald D Iii | Method and apparatus for electromagnetic ablation of biological tissue |
RU2334530C2 (en) * | 2006-03-09 | 2008-09-27 | Вадим Дмитриевич Гончаров | Method of local heating of internal tissues of human body |
WO2007124458A2 (en) * | 2006-04-20 | 2007-11-01 | The Regents Of The University Of California | Method of thermal treatment for myolysis and destruction of benign uterine tumors |
US20090221999A1 (en) * | 2008-02-29 | 2009-09-03 | Ramin Shahidi | Thermal Ablation Design and Planning Methods |
-
2009
- 2009-10-12 CN CN200980143525.8A patent/CN102202735B/en not_active Expired - Fee Related
- 2009-10-12 EP EP09741431.2A patent/EP2352558B1/en not_active Not-in-force
- 2009-10-12 BR BRPI0914520A patent/BRPI0914520A2/en not_active IP Right Cessation
- 2009-10-12 US US13/126,188 patent/US20110208055A1/en not_active Abandoned
- 2009-10-12 RU RU2011122671/14A patent/RU2519378C2/en not_active IP Right Cessation
- 2009-10-12 WO PCT/IB2009/054483 patent/WO2010052596A1/en active Application Filing
- 2009-10-12 JP JP2011533859A patent/JP5948057B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003076003A2 (en) * | 2002-03-06 | 2003-09-18 | Tomotherapy Incorporated | Method for modification of radiotherapy treatment delivery |
US20060293583A1 (en) * | 2005-06-27 | 2006-12-28 | Saracen Michael J | Method for automatic anatomy-specific treatment planning protocols based on historical integration of previously accepted plans |
US20070010805A1 (en) * | 2005-07-08 | 2007-01-11 | Fedewa Russell J | Method and apparatus for the treatment of tissue |
WO2007014026A2 (en) * | 2005-07-22 | 2007-02-01 | Tomotherapy Incorporated | System and method of detecting a breathing phase of a patient receiving radiation therapy |
US20070076846A1 (en) * | 2005-07-22 | 2007-04-05 | Ruchala Kenneth J | System and method of delivering radiation therapy to a moving region of interest |
WO2007123913A1 (en) * | 2006-04-17 | 2007-11-01 | Siemens Medical Solutions Usa, Inc. | Personalized prognosis modeling in medical treatment planning |
US20080033420A1 (en) * | 2006-08-04 | 2008-02-07 | Nields Morgan W | Methods for planning and performing thermal ablation |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102762160A (en) * | 2010-06-17 | 2012-10-31 | 奥林巴斯医疗株式会社 | Ultrasound suction system and ultrasound suction method |
EP2684581A1 (en) * | 2012-07-10 | 2014-01-15 | Samsung Electronics Co., Ltd | Method and apparatus for generating irradiation plan to be provided to focused ultrasound irradiation apparatus |
WO2016151111A1 (en) * | 2015-03-26 | 2016-09-29 | Koninklijke Philips N.V. | System and method for tumor ablation treatment planning including core tumor, margin and healthy tissue coverage |
CN107530131A (en) * | 2015-03-26 | 2018-01-02 | 皇家飞利浦有限公司 | For the system and method for the tumour ablation circular economy covered including core tumour, edge and health tissues |
CN107530131B (en) * | 2015-03-26 | 2021-02-26 | 皇家飞利浦有限公司 | System and method for tumor ablation treatment planning |
EP3628251A1 (en) * | 2018-09-28 | 2020-04-01 | Koninklijke Philips N.V. | Ablation therapy planning system |
WO2020064659A1 (en) * | 2018-09-28 | 2020-04-02 | Koninklijke Philips N.V. | Ablation therapy planning system |
Also Published As
Publication number | Publication date |
---|---|
BRPI0914520A2 (en) | 2015-12-15 |
JP2012507324A (en) | 2012-03-29 |
RU2519378C2 (en) | 2014-06-10 |
EP2352558A1 (en) | 2011-08-10 |
EP2352558B1 (en) | 2014-07-02 |
RU2011122671A (en) | 2012-12-20 |
CN102202735A (en) | 2011-09-28 |
CN102202735B (en) | 2017-02-22 |
JP5948057B2 (en) | 2016-07-06 |
US20110208055A1 (en) | 2011-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2352558B1 (en) | System for ultrasound therapy | |
US7771418B2 (en) | Treatment of diseased tissue using controlled ultrasonic heating | |
RU2532291C2 (en) | System and method of treating by ultrasonic therapy | |
US9205282B2 (en) | System and method for control and monitoring of conformal thermal therapy | |
US20070239062A1 (en) | Method and apparatus for obtaining quantitative temperature measurements in prostate and other tissue undergoing thermal therapy treatment | |
TW201034628A (en) | Ultrasonic treatment of adipose tissue at multiple depths | |
JP2012510332A (en) | A feedback system that integrates interventional planning and navigation | |
JPH10328194A (en) | Ultrasonic therapy instrument | |
KR20140113172A (en) | Method and apparatus for making a plan of ultrasonic irradiation, and an ultrasonic irradiation method | |
JP6088653B2 (en) | Ultrasonic volume flow measurement for ablation treatment | |
Mast et al. | Treatment of rabbit liver cancer in vivo using miniaturized image-ablate ultrasound arrays | |
Dera et al. | Experimental evaluation of targeting accuracy of ultrasound imaging-guided robotic HIFU ablative system for the treatment of solid tumors in pre-clinical studies | |
Daunizeau et al. | Robot-assisted ultrasound navigation platform for 3D HIFU treatment planning: Initial evaluation for conformal interstitial ablation | |
RU2651875C2 (en) | Ultrasonic measurement of the volume flow for ablation planning | |
JP2021505330A (en) | Automatic excision antenna segmentation from CT images | |
KR20120117510A (en) | Apparatus for ultrasound treatment and driving method thereof | |
US20240350153A1 (en) | Histotripsy systems and associated methods including user interfaces and workflows for treatment planning and therapy | |
Burdette et al. | Conformal needle-based ultrasound ablation using EM-tracked conebeam CT image guidance | |
Chen et al. | Clinical external ultrasonic treatment devices | |
Gandomi et al. | ICAP: Interactive Conformal Ablation Planning Toolkit with MR Thermometry Validation | |
Evripidou et al. | Workflow of a Preclinical Robotic Magnetic Resonance Imaging-guided Focused Ultrasound Body System | |
WO2024221001A2 (en) | Histotripsy systems and associated methods including user interfaces and workflows for treatment planning and therapy | |
Bendl et al. | Planning and Optimisation of Stereotactic Laser-Neurosurgery | |
Ng | Robotic HIFU for the treatment of prostate cancer | |
Wu et al. | Lili Chen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980143525.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09741431 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009741431 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13126188 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011533859 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3645/CHENP/2011 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011122671 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: PI0914520 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110429 |